FLUOXETINE HYDROCHLORIDE (fluoxetine) by Charter Medical is 12. Approved for depressive episodes associated with bipolar i disorder, the treatment of treatment resistant depression, depression. First approved in 2009.
Drug data last refreshed 21h ago
12.2. Pharmacodynamics Studies at clinically relevant doses in man have demonstrated that fluoxetine blocks the uptake of serotonin into human platelets. Studies in animals also suggest that fluoxetine is a much more potent uptake inhibitor of serotonin than of norepinephrine. Antagonism of…
Worked on FLUOXETINE HYDROCHLORIDE at Charter Medical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Fluoxetine and Understanding Social Experiences
Fluoxetine on Emotional Experience (FLEX) Study
Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine
Fluoxetine vs CBT in Childhood Anxiety Disorders
Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine Treatment